SEARCH

SEARCH BY CITATION

References

  • 1
    Kendler KS, McGuire M, Gruenberg AM, O'HARE A, Spellman M, Walsh D. The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch Gen Psychiatry 1993;50:527540.
  • 2
    Kendler KS, McGuire M, Gruenberg AM, O'HARE A, Spellman M, Walsh D. The Roscommon Family Study. III. Schizophrenia-related personality disorders in relatives. Arch Gen Psychiatry 1993;50:781788.
  • 3
    Kendler KS, Gardner CO. The risk for psychiatric disorders in relatives of schizophrenic and control probands: a comparison of three independent studies. Psychol Med 1997;27:411419.
  • 4
    Van Os J, Marcelis M, Sham P, Jones P, Gilvarry K, Murray R. Psychopathological syndromes and familial morbid risk of psychosis. Br J Psychiatry 1997;170:241246.
  • 5
    Lataster T, Myin-Germeys I, Derom C, Thiery E, Van Os J. Evidence that self-reported psychotic experiences represent the transitory developmental expression of genetic liability to psychosis in the general population. Am J Med Genet B Neuropsychiatr Genet 2009;150B:10781084.
  • 6
    Fanous A, Gardner C, Walsh D, Kendler KS. Relationship between positive and negative symptoms of schizophrenia and schizotypal symptoms in nonpsychotic relatives. Arch Gen Psychiatry 2001;58:669673.
  • 7
    Mata I, Gilvarry CM, Jones PB, Lewis SW, Murray RM, Sham PC. Schizotypal personality traits in nonpsychotic relatives are associated with positive symptoms in psychotic probands. Schizophr Bull 2003;29:273283.
  • 8
    Mata I, Sham PC, Gilvarry CM, Jones PB, Lewis SW, Murray RM. Childhood schizotypy and positive symptoms in schizophrenic patients predict schizotypy in relatives. Schizophr Res 2000;44:129136.
  • 9
    Chen LS, Rice TK, Thompson PA, Barch DM, Csernansky JG. Familial aggregation of clinical and neurocognitive features in sibling pairs with and without schizophrenia. Schizophr Res 2009;111:159166.
  • 10
    Lindenmayer JP, Bernstein-Hyman R, Grochowski S. Five-factor model of schizophrenia. Initial validation. J Nerv Ment Dis 1994;182:631638.
  • 11
    McGrath JA, Avramopoulos D, Lasseter VK et al. Familiality of novel factorial dimensions of schizophrenia. Arch Gen Psychiatry 2009;66:591600.
  • 12
    Nuechterlein KH, Asarnow RF, Subotnik KL et al. The structure of schizotypy: relationships between neurocognitive and personality disorder features in relatives of schizophrenic patients in the UCLA Family Study. Schizophr Res 2002;54:121130.
  • 13
    Vollema MG, Van Den Bosch RJ. The multidimensionality of schizotypy. Schizophr Bull 1995;21:1931.
  • 14
    Kwapil TR, Barrantes-Vidal N, Silvia PJ. The dimensional structure of the Wisconsin Schizotypy Scales: factor identification and construct validity. Schizophr Bull 2008;34:444457.
  • 15
    Craver JC, Pogue-Geile MF. Familial liability to schizophrenia: a sibling study of negative symptoms. Schizophr Bull 1999;25:827839.
  • 16
    Korver N, Quee PJ, Boos HB, Simons CJ, De Haan L. Genetic Risk and Outcome of Psychosis (GROUP), a multi site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods. Int J Methods Psychiatr Res 2012;21:205221.
  • 17
    APA. Diagnostic and statistical manual of mental disorders, 4th edn, Text Revision. Washington, DC: American Psychiatric Association, 2000.
  • 18
    Andreasen N, Flaum M, Arndt S. The comprehensive assessment of symptoms and history (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 1992;49:615623.
  • 19
    Wing JK, Babor T, Brugha T et al. SCAN. Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 1990;47:589593.
  • 20
    Konings M, Bak M, Hanssen M, Van Os J, Krabbendam L. Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population. Acta Psychiatr Scand 2006;114:5561.
  • 21
    Stefanis NC, Hanssen M, Smirnis NK et al. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med 2002;32:347358.
  • 22
    Peters ER, Joseph SA, Garety PA. Measurement of delusional ideation in the normal population: introducing the PDI (Peters et al. Delusions Inventory). Schizophr Bull 1999;25:553576.
  • 23
    Vollema MG, Ormel J. The reliability of the structured interview for schizotypy-revised. Schizophr Bull 2000;26:619629.
  • 24
    G.R.O.U.P. Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis. Arch Gen Psychiatry 2010;68:138147.
  • 25
    Statacorp. STATA Statistical Software: release 11.0. Texas, College Station: StataCorp LD, 2009.
  • 26
    Van Os J, Kenis G, Rutten BP. The environment and schizophrenia. Nature 2010;468:203212.
  • 27
    Wigman JT, Van Winkel R, Ormel J, Verhulst FC, Van Os J, Vollebergh WA. Early trauma and familial risk in the development of the extended psychosis phenotype in adolescence. Acta Psychiatr Scand 2012;126:266273.
  • 28
    Read J, Van Os J, Morrison AP, Ross CA. Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatr Scand 2005;112:330350.
  • 29
    Janssen I, Krabbendam L, Bak M et al. Childhood abuse as a risk factor for psychotic experiences. Acta Psychiatr Scand 2004;109:3845.
  • 30
    Henquet C, Murray R, Linszen D, Van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull 2005;31:608612.
  • 31
    Dragt S, Nieman DH, Schultze-Lutter F et al. Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis. Acta Psychiatr Scand 2012;125:4553.
  • 32
    Rutten BP, Mill J. Epigenetic mediation of environmental influences in major psychotic disorders. Schizophr Bull 2009;35:10451056.
  • 33
    Xu B, Roos JL, Dexheimer P et al. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet 2011;43:864868.
  • 34
    Girard SL, Gauthier J, Noreau A et al. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet 2011;43:860863.
  • 35
    Glatt SJ, Stone WS, Nossova N, Liew N, Seidman LJ, Tsuang C-C. Similarities and differences in peripheral blood gene-expression signatures of individuals with schizophrenia and their first-degree biological relatives. Am J Med Genet B Neuropsychiatr Genet 2011;156B:869887.
  • 36
    Kendler KS, Karkowski-Shuman L, O'Neill FA, Straub RE, Maclean CJ, Walsh D. Resemblance of psychotic symptoms and syndromes in affected sibling pairs from the Irish Study of high-density schizophrenia families: evidence for possible etiologic heterogeneity. Am J Psychiatry 1997;154:191198.
  • 37
    Appels MCM, Sitskoorn MM, Vollema MG, Kahn RS. Elevated levels of schizotypal features in parents of patients with a family history of schizophrenia spectrum disorders. Schizophr Bull 2004;30:781790.